Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2012
09/13/2012US20120232074 Imidazo [4, 5-C] Quinoline Derivatives As Bromodomain Inhibitors
09/13/2012US20120232072 Imidazopyridine derivatives
09/13/2012US20120232062 Azaindazoles to treat flaviviridae virus infection
09/13/2012US20120232057 CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS
09/13/2012US20120232052 Aryl carboxamide derivatives as ttx-s blockers
09/13/2012US20120232019 Compositions and Methods for Treatment of Eye Disorders
09/13/2012US20120231995 Use of pyrroloquinoline compounds to kill clinically latent microorganisms
09/13/2012US20120231543 Novel opioid antagonists
09/13/2012US20120228598 Compound having a substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent device
09/13/2012US20120228552 Materials for organic electroluminescent devices
09/13/2012US20120227802 Organic compound and photovoltaic device comprising the same
09/13/2012DE102011013897A1 Organische Solarzelle Organic solar cell
09/13/2012CA2829287A1 Pyrido [2,3-b] pyrazine derivatives and their therapeutical uses
09/13/2012CA2829188A1 Dispiropyrrolidine derivatives
09/13/2012CA2828578A1 Mst1 kinase inhibitors and methods of their use
09/12/2012EP2497771A1 4 -substituted azaadamantane derivatives and methods of use thereof
09/12/2012EP2497770A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
09/12/2012EP2497769A1 Pyrroloquinoline quinone in free form
09/12/2012EP2496579A1 1-substituted 2-azabicyclo [3.1.1]heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders
09/12/2012EP2496578A2 Imidazo[1,2-a]pyridine compounds, synthesis thereof, and methods of using same
09/12/2012EP2496577A1 Imidazopyridine derivatives
09/12/2012EP2496576A1 Imidazo [4, 5-c]quinoline derivates as bromodomain inhibitors
09/12/2012EP2496575A1 Heterocyclic sulfonamide derivatives useful as mek inhibitors
09/12/2012EP2496574A1 Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition
09/12/2012EP2496559A1 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
09/12/2012EP2496234A1 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors
09/12/2012CN102666540A Condensed azine-derivatives for the treatment of diseases related to the acetylcholine receptor
09/12/2012CN102666538A Pyrrolopyridinyl-pyrimidin-2-ylamine derivatives
09/12/2012CN102666537A Azaindazoles to treat flaviviridae virus infection
09/12/2012CN102666536A Novel naphthyridine derivatives and the use thereof as kinase inhibitors
09/12/2012CN102666535A Imidazole derivatives as aldosterone synthase inhibitors
09/12/2012CN102666534A Phenanthroline derivatives and their use as ligands
09/12/2012CN102666533A Treatment of cancer
09/12/2012CN102666526A Indazole and pyrazolopyridine compounds as ccr1 receptor antagonists
09/12/2012CN102666507A Oxazine derivatives and their use in the treatment of neurological disorders
09/12/2012CN102666495A Potassium channel modulators
09/12/2012CN102666491A Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
09/12/2012CN102659784A Method for preparing high-purity aloperine
09/12/2012CN102659783A N-substituted sophora flavescens olefine acid derivative as well as preparation method and application thereof
09/12/2012CN102659782A Evodiamine derivative, preparation method and application thereof
09/12/2012CN102659781A Extracting method of dihydrocorynantheine
09/12/2012CN102659780A Preparation method of 2-allylaminopyrazolyl[5,1-a]isoquinoline compound
09/12/2012CN102659779A Method extracting salsoline A from salsola collina
09/12/2012CN102659778A Novel synthesis technology of 6-amino-2-methyl-3H-imidazo [4, 5-b] pyridine
09/12/2012CN102241674B Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester
09/12/2012CN101277955B Cyclic amine compound and pest control agent
09/11/2012US8263657 Blocking neurokinins; using a benzene compound containing hydroxy or acetoxy group; antiinflammatory agents
09/11/2012US8263616 4,5,6,7-tetrahydroimidazo[4,5-c]pyridine compounds
09/11/2012US8263615 Bis-heterocyclic imidazolyl compounds
09/11/2012US8263614 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
09/11/2012US8263613 Salts, prodrugs and polymorphs of fab I inhibitors
09/11/2012US8263610 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds
09/11/2012US8263609 Tetrahydro-β-carbolin-sulfonamide derivatives as 5-Ht6 ligands
09/11/2012US8263595 Triazolopyridine compounds and their use as ask inhibitors
09/11/2012US8263594 Aryloxy and arylalkyleneoxy substituted imidazoquinolines
09/11/2012US8263584 Imidazopyridines
09/11/2012CA2445159C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
09/07/2012WO2012118850A1 Serine/threonine kinase inhibitors
09/07/2012WO2012118812A2 Substituted 6,5-fused bicyclic heteroaryl compounds
09/07/2012WO2012117996A1 Gpr119 agonist
09/07/2012WO2012117224A1 Dipyridinium derivatives
09/07/2012WO2012117089A1 Perylene-based semiconducting materials
09/07/2012WO2012117048A1 Pharmaceutically active disubstituted triazine derivatives
09/07/2012WO2012116989A1 Substituted heteroaryl 2', 3', 7', 7a' - tetrahydrospiro-[pyrrole-3, 6' - pyrrolo [1, 2-c] imidazole] - 1', 2 (1h, 5'h) -diones as anticancer agents
09/07/2012WO2012116965A1 Bridged piperidine derivatives
09/07/2012WO2012116960A1 2-acyloxy-pyrrolin-4-ones
09/07/2012CA2828639A1 2-acyloxypyrrolin-4-ones
09/07/2012CA2828636A1 Dipyridinium derivatives
09/07/2012CA2828478A1 Serine/threonine kinase inhibitors
09/07/2012CA2826464A1 Pharmaceutically active disubstituted triazine derivatives
09/07/2012CA2824239A1 Bridged piperidine derivatives
09/06/2012US20120226045 Pyrroloquinoline quinone in free form
09/06/2012US20120226042 Perylene-based Semiconducting Materials
09/06/2012US20120226035 Novel heterocyclic compound or salt thereof and intermediate thereof
09/06/2012US20120226033 4-alkoxy-n- (2-hydroxycarbamoyl-2-piperidinyl-ethyl) -benzamide compounds as selective tace-inhibitors for the treatment of inflammatory diseases
09/06/2012US20120225904 New 7-Phenyl-[1,2,4]triazolo[4,3-a]Pyridin-3(2H)-One Derivatives
09/06/2012US20120225900 N2-pyrazolospiroketone acetyl-coa carboxylase inhibitors
09/06/2012US20120225890 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
09/06/2012US20120225887 Glucokinase Activators
09/06/2012US20120225886 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
09/06/2012US20120225885 Imidazole derivatives and methods of use thereof
09/06/2012US20120225884 Bridged piperidine derivatives
09/06/2012US20120225875 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors
09/06/2012US20120225874 Bicyclic derivatives as cetp inhibitors
09/06/2012US20120225873 Compounds for alzheimer's disease
09/06/2012US20120225871 Small-molecule modulators of trp-p8 activity
09/06/2012US20120225859 Pyrimidine derivatives used as pi-3 kinase inhibitors
09/06/2012US20120225856 Fused ring azadecalin glucocorticoid receptor modulators
09/06/2012US20120225855 Triazolopyridine jak inhibitor compounds and methods
09/06/2012US20120225854 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes
09/06/2012US20120225846 Heterocyclic compounds for the inhibition of pask
09/05/2012EP2495780A1 Organic semiconductor material, organic semiconductor thin film, and organic thin film transistor
09/05/2012EP2495016A1 Bicyclic Heteroaryl Compounds
09/05/2012EP2494975A1 Compounds and methods for promoting smoking cessation
09/05/2012EP2493888A1 Bicyclic pyridines and analogs as sirtuin modulators
09/05/2012EP2493876A1 Imidazole derivatives as casein kinase inhibitors
09/05/2012EP2493875A1 Heterocyclic compounds as ccr1 receptor antagonists
09/05/2012EP2493871A1 Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors
09/05/2012EP2493865A2 Raf inhibitor compounds and methods of use thereof
09/05/2012EP2493469A2 Pharmaceutical composition comprising indole compound
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 646